Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease... see more

TSX:SZLS - Post Discussion

StageZero Life Sciences Ltd > LinkedIn yesterday
View:
Post by LithLover on Nov 22, 2022 10:49am

LinkedIn yesterday

StageZero Life Sciences Ltd. (TSX: SZLS)

Finding cancer early is a crucial strategy for improving cancer outcomes. Unfortunately, almost 50% of people are diagnosed too late when outcomes are poor.(1) Early Cancer Detection Matters!

ARISTOTLE® is a new blood test that can detect the molecular signatures of multiple cancers from a single blood sample to help you find cancer earlier.Learn more at:

https://ow.ly/YSVT50LHuhK

#EarlyMeansEverything #Liquid Biopsy
#SZLS#SZLSF

1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021 Jan;71(1):7-33
No alternative text description for this image
Comment by Liked2Think on Nov 22, 2022 11:40am
And how many people follow their LinkedIn page?
Comment by brad129 on Nov 22, 2022 12:10pm
doesn't really matter how many, It only takes one or two influential people in the right position.  
Comment by Liked2Think on Nov 22, 2022 12:33pm
  man's if they have 50 followers the likelihood of that white knight is slim to none  you people are grasping at straws to pump this back up  
Comment by Nailbiter2 on Nov 22, 2022 12:16pm
This post has been removed in accordance with Community Policy
Comment by Liked2Think on Nov 22, 2022 12:35pm
I will stop when the sp of this "great company" goes above a sad and payhetic 10 cents 
Comment by Nailbiter2 on Nov 22, 2022 12:41pm
This post has been removed in accordance with Community Policy
Comment by Liked2Think on Nov 22, 2022 12:43pm
sorry I point out all the bs with this company i guess it hurts the bs pump 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities